Home LiteratureArticle Details
PMID: 10454208 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

CK2: a protein kinase in need of control.

Pharmacology & therapeutics ·Vol. 82 ·No. 2-3 ·1999-00-00 ·Pages 303-13

Guerra B, Boldyreff B, Sarno S, Cesaro L, Issinger OG, Pinna LA

Abstract

Protein kinase CK2 is a heterotetrameric alpha2beta2 Ser/Thr protein kinase with some features unusual among the eukaryotic protein kinases: (1) CK2 recognizes phosphoacceptor sites specified by several acidic determinants; (2) CK2 can use both ATP and GTP as phosphoryl donors; and (3) the regulatory properties of CK2 are poorly understood; it is insensitive to any known second messenger and displays high basal activity. To gain insight into CK2 regulation and to understand its unusual properties, site-directed mutagenesis experiments on both subunits and X-ray crystallographic studies of the catalytic alpha-subunit were performed. The noncatalytic beta-subunit has at least three functions: (1) it protects the alpha-subunit against denaturing agents or conditions; (2) it alters the substrate specificity of the alpha-subunit; and (3) it modulates the activity of the enzyme, i.e., depending on the substrate, it increases or decreases the activity of the alpha-subunit. Mutagenesis experiments revealed that an acidic stretch between amino acids 55 and 64 has a down-regulatory and autoinhibitory function. Mutational analysis of the alpha-subunit has revealed a network of unique basic residues that are responsible for the recognition of phosphoacceptor substrates and for down-regulation by the beta-subunit and by polyanionic inhibitors. The resolution of the crystal structure of Zea mays CK2 alpha-subunit has disclosed the structural features that are responsible for high basal activity and for unusual response to nucleotide analogs. The increasing knowledge of CK2 structure-function relationships will allow the design of highly selective inhibitors of this pleiotropic kinase with oncogenic potential.

MeSH Terms
Amino Acid Sequence Casein Kinase II Catalytic Domain/physiology Enzyme Inhibitors/pharmacology Models, Molecular Molecular Sequence Data Molecular Structure Protein Serine-Threonine Kinases/antagonists & inhibitors,chemistry Sensitivity and Specificity
Chemicals
Enzyme Inhibitors Casein Kinase II Protein Serine-Threonine Kinases
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Guerra B
Biokemisk Institut, Odense Universitet, Denmark.
Boldyreff B
Sarno S
Cesaro L
Issinger O G
Pinna L A
Article Info
Journal
Pharmacology & therapeutics
Abbr.
Pharmacol Ther
ISSN
0163-7258
Published
1999-00-00
Pages
303-13
Language
English
Region
England
NLM ID
7905840
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com